Lincocin Injection, Solution
Product Images NDC 0009-0107

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lincocin (NDC 0009-0107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lincocin 01)

Chemical structure of the active ingredient in Lincocin 300 mg/mL, depicting a complex molecular arrangement including rings, hydroxyl groups, and functional groups, consistent with a beta-lactam antibiotic compound.*

FDA Label Image

Logo (Lincocin 02)

FDA Label Image

Principal Display Panel (1-2 mL Vial Label)

Lincocin 300 mg/mL injection, USP vial label showing a 1-2 mL vial. The label includes Pfizer as the manufacturer and Pharmacia & Upjohn Co as the distributor. It provides storage instructions for controlled room temperature (20° to 25°C) and dosage and use information referring to prescribing information. The label states for intramuscular or intravenous use and is marked Rx only.*

FDA Label Image

Principal Display Panel (1-2 mL Vial Carton)

Packaging label for Lincocin lincomycin injection, USP, 300 mg/mL in a 1-2 mL vial. The label states the product is for intramuscular or intravenous use and includes storage instructions, dosage use notes, and a warning about dilution if given intravenously. Distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc.*

FDA Label Image

Lincocin 05

Lincocin lincomycin injection, USP label for a 2 mL multiple-dose vial with a strength of 600 mg/2 mL (300 mg/mL). The label indicates it is for intramuscular or intravenous use, prescription only, and is distributed by Pharmacia & Upjohn Company LLC, a Pfizer division. Storage instructions specify controlled room temperature from 20° to 25°C (68° to 77°F).*

FDA Label Image

Lincocin 06

Packaging label for Lincocin lincomycin injection, USP 600 mg/2 mL (300 mg/mL) by Pharmacia & Upjohn Company LLC. The label indicates use for intramuscular or intravenous administration, specifies one 2 mL multiple-dose vial, includes storage instructions, warnings, and a barcode. The label also mentions the active ingredient lincomycin hydrochloride USP equivalent to 300 mg lincomycin per mL and a benzyl alcohol preservative.*

FDA Label Image

Lincocin 07

Lincocin lincomycin injection, USP 3,000 mg/10 mL (300 mg/mL) multiple-dose vial label. Distributed by Pharmacia & Upjohn Company LLC, it is for intramuscular or intravenous use, Rx only. The label includes storage instructions at 20° to 25°C (68° to 77°F) and a warning that intravenous use requires dilution before administration.*

FDA Label Image

Lincocin 08

Packaging label for Lincocin lincomycin injection, USP, 3,000 mg/10 mL (300 mg/mL) in a 10 mL multiple-dose vial. The label indicates use for intramuscular or intravenous administration and is distributed by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc. The label includes storage instructions, a warning about dilution if given intravenously, and ingredient information including benzyl alcohol as preservative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.